NCT04588363 - COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C | Biotech Hunter

Enrollment

244

Participants

Timeline

Start Date

November 19, 2020

Primary Completion Date

March 3, 2023

Study Completion Date

March 3, 2023

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Multisystem Inflammatory Syndrome in Children (MIS-C)Coronavirus Disease 2019 (COVID-19)

Interventions

OTHER

SARS-CoV-2 and/or MIS-C Exposure

This is an observational cohort study.

Trial Locations (20)

10016

Hassenfeld Children's Hospital at NYU Langone, New York

10021

NewYork-Presbyterian Komansky Children's Hospital, New York

10029

Mount Sinai Kravis Children's Hospital, New York

10467

Children's Hospital at Montefiore, The Bronx

11040

Cohen Children's Medical Center - Northwell Health, New Hyde Park

11215

NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn

11355

NewYork-Presbyterian Queens Hospital, Flushing

15224

UPMC Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

27710

Duke University Children's Health Center, Durham

29425

Medical University of South Carolina, Pediatric Rheumatology, Charleston

30322

Children's Healthcare of Atlanta, Atlanta

37232

Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

55905

Mayo Clinic Rochester, Rochester

63110

St. Louis Children's Hospital, St Louis

90048

Cedars-Sinai Medical Center, Los Angeles

91011

Children's Hospital Los Angeles, Los Angeles

92354

Loma Linda University Health, Loma Linda

94303

Lucile Packard Children's Hospital Stanford, Palo Alto

All Listed Sponsors

collaborator

Autoimmunity Centers of Excellence

OTHER

collaborator

Clinical Trials in Organ Transplantation in Children

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH